Chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis, can leave sufferers feeling tired, even after sleep, and may lead to problems with memory and concentration.
CFS cases have exploded during the COVID-19 pandemic and some doctors are using novel methods to treat the condition—including ivermectin, which was called a “wonder drug” for human health before the pandemic.
Nearly 80 Percent Report Post-COVID CFS
A recent questionnaire-based study published in the journal Neurology International found that nearly 80 percent of patients with COVID-19 had one or more persistent symptoms post-infection and 58 percent met the case definition for CFS.
George Citroner
Author
George Citroner reports on health and medicine, covering topics that include cancer, infectious diseases, and neurodegenerative conditions. He was awarded the Media Orthopaedic Reporting Excellence (MORE) award in 2020 for a story on osteoporosis risk in men.
